BRIO SIRIC scientific day 2

évènement
Mise en ligne : 07 novembre 2014
DOI : 10.60527/0qhs-0v60
URL pérenne : https://doi.org/10.60527/0qhs-0v60
  • niveau 1 niveau 2 niveau 3
  • document 1 document 2 document 3
Expert panel discussions : why translational research matters
BRIO support to scientists
Conférence
00:13:28

BRIO support to scientists

Dessis
Damien

BRIO management team was voluntarily built upon various competencies from different horizons (industry, charity…) to provide a broad skillset which aims at supporting the Bordeaux cancer research

Bordeaux Cancer Initiative
Conférence
00:16:54

Bordeaux Cancer Initiative

Dessis
Damien
Elustondo
Frédéric

Translational science : how to move from biology to clinical applications Upon request of the University, the SIRIC was mandated to develop a transversal cancer axis at the University. The axis

Multisarc
Conférence
00:13:08

Multisarc

Italiano
Antoine

Translational science : how to move from biology to clinical applications Soft-tissues sarcomas represent an heterogeneous group of tumors. Stadard of care is surgical resection followed by

Curing leukemia ?
Conférence
00:19:52

Curing leukemia ?

Mahon
François-Xavier

Non-pharmaceutical medical innovations and public health The use of tyrosine kinase inhibitors (TKIs) targeted against the BCR-ABL1 oncoprotein has proven remarkably successful in chronic myeloid

Standardizing G8 evaluation
Conférence
00:15:00

Standardizing G8 evaluation

Soubeyran
Pierre

Non-pharmaceutical innovations and public health Management of the frail elderly with cancer is a challenge. Beside a poor outcome as compared to younger subjects, physicians will face increased

Innovation reimbursement
Conférence
00:09:10

Innovation reimbursement

Fillatreau
Christian

Interface technology/clinical/SHS/public health : case study interventional radiology Novel diagnostic and therapeutic strategies is a continuum of 3 strongly associated phases : clinical

Intervenants et intervenantes